Specific recruitment of γδ regulatory T cells in human breast cancer

Cancer Research

Volumn 73, Issue 20, 2013, Pages 6137-6148

  Ye, Jian ^a   Ma, Chunling ^a,c   Wang, Fang ^a   Hsueh, Eddy C ^a   Toth, Karoly ^a   Huang, Yi ^a   Mo, Wei ^a   Liu, Shuai ^a   Han, Bing ^a   Varvares, Mark A ^b   Hoft, Daniel F ^a   Peng, Guangyong ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Shandong Medical College   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR3; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; RANTES; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER INHIBITION; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FLOW CYTOMETRY; GAMMA DELTA 1 REGULATORY T CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MOUSE; NOD SCID MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T CELL RECRUITMENT; REGULATORY T LYMPHOCYTE; TH17 CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, INBRED NOD; MICE, SCID; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES, REGULATORY; TUMOR MICROENVIRONMENT;

EID: 84886040918     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-0348     Document Type: Article

References (52)

1. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006; 6:295-307.
2. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182:18-32.
3. Liyanage UK, Moore TT, Joo H.G., Tanaka Y., Herrmann V, Doherty G, et al Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002; 169:2756-61.
4. Wolf AM, Wolf D, Steurer M., Gastl G, Gunsilius E, Grubeck-Loebenstein B. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003; 9:606-12.
5. Curiel TJ, Coukos G, Zou L., Alvarez X, Cheng P, Mottram P., et al Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942-9.
6. + CD4 T cells in vivo after CD25 directed recombinant immunotoxin administration. J Immunother 2008; 31:189-98.
7. Morse MA, Hobeika AC, Osada T, Serra D., Niedzwiecki D, Lyerly HK, et al Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines. Blood 2008; 112:610-8.
8. high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer. J Surg Res 2005; 124: 151-7.
9. +) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009; 16:91-102.
10. Gobert M, Treilleux I, Bendriss-Vermare N, Bachelot T., Goddard-Leon S, Arfi V, et al Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res 2009; 69: 2000-9.
11. Bates GJ, Fox SB, Han C, Leek R.D., Garcia JF, Harris AL, et al Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 2006; 24:5373-80.
12. Powell DJ J.r., Felipe-Silva A, Merino M.J., Ahmadzadeh M., Allen T, Levy C, et al Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo. J Immunol 2007; 179: 4919-28.
13. Moore AC, Gallimore A, Draper S.J., Watkins KR, Gilbert SC, Hill AV Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance. J Immunol 2005; 175:7264-73.
14. + T cells in a dose-dependent fashion. Blood 2008; 112:1175-83.
15. Roncarolo MG, Gregori S, Battaglia M., Bacchetta R, Fleischhauer K, Levings MK Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006; 212:28-50.
16. Gajewski TF. The expanding universe of regulatory T cell subsets in cancer. Immunity 2007; 27:185-7.
17. + regulatory T cells mediate immunosuppression in prostate cancer. Clin Cancer Res 2007; 13:6947-58.
18. +regulatory T cells in human ovarian carcinoma. Cancer Res 2005; 65:5020-6.
19. Peng G, Wang HY, Peng W, Kiniwa Y., Seo KH, Wang RF Tumorinfiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity 2007; 27:334-48.
20. Hayday A, Tigelaar R. Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol 2003; 3:233-42.
21. Kapp JA, Kapp LM, McKenna KC Gammadelta T cells play an essential role in several forms of tolerance. Immunol Res 2004; 29: 93-102.
22. + gammadelta T regulatory cells mediate kidney allograft prolongation after oral exposure to alloantigen. Transpl Int 2008; 21:679-87.
23. Locke NR, Stankovic S, Funda D.P., Harrison LC TCR gamma delta intraepithelial lymphocytes are required for self-tolerance. J Immunol 2006; 176:6553-9.
24. + T cells to lung and subsequent pulmonary fibrosis. J Immunol 2006; 177:4436-43.
25. Li X, Kang N, Zhang X., Dong X, Wei W, Cui L., et al Generation of human regulatory gammadelta T cells by TCRgammadelta stimulation in the presence of TGF-beta and their involvement in the pathogenesis of systemic lupus erythematosus. J Immunol 2011; 186:6693-700.
26. + uveitogenic T cells. Invest Ophthalmol Vis Sci 2010; 51:4661-7.
27. Petermann F, Rothhammer V, Claussen M.C., Haas JD, Blanco LR, Heink S, et al gammadelta T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity 2010; 33:351-63.
28. Kapp JA, Kapp LM, McKenna K.C., Lake JP gammadelta T-cell clones from intestinal intraepithelial lymphocytes inhibit development of CTL responses ex vivo. Immunology 2004; 111:155-64.
29. Ke Y, Kapp LM, Kapp JA Inhibition of tumor rejection by gammadelta T cells and IL-10. Cell Immunol 2003; 221:107-14.
30. Seo N, Tokura Y, Takigawa M., Egawa K. Depletion of IL-10- and TGFbeta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells. J Immunol 1999; 163:242-9.
31. Ma C, Zhang Q, Ye J., Wang F, Zhang Y, Wevers E., et al Tumorinfiltrating gammadelta T lymphocytes predict clinical outcome in human breast cancer. J Immunol 2012; 189:5029-36.
32. Ye J, Ma C, Hsueh E.C., Eickhoff CS, Zhang Y, Varvares MA, et al Tumor-derived gammadelta regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence. J Immunol 2013; 190:2403-14.
33. Traxlmayr MW, Wesch D, Dohnal A.M., Funovics P., Fischer MB, Kabelitz D, et al Immune suppression by gammadelta T-cells as a potential regulatory mechanism after cancer vaccination with IL-12 secreting dendritic cells. J Immunother 2010; 33:40-52.
34. + regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res 2004; 64:8451-5.
35. Tan MC, Goedegebuure PS, Belt B.A., Flaherty B., Sankpal N, Gillanders WE, et al Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol 2009; 182:1746-55.
36. Ishida T, Ishii T, Inagaki A., Yano H, Komatsu H, Iida S., et al Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege. Cancer Res 2006; 66: 5716-22.
37. + T-cell pool and tumor trafficking in patients with ovarian carcinoma. Cancer Res 2007; 67:7487-94.
38. Su X, Ye J, Hsueh E.C., Zhang Y., Hoft DF, Peng G. Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol 2010; 184:1630-41.
39. +) T cells with potent suppressive function. Eur J Immunol 2011; 41:936-51.
40. Groom JR, Luster AD CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 2011; 89:207-15.
41. Georgiannos SN, Renaut A, Goode A.W., Sheaff M. The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cellmediated immune mechanisms, and their association with prognostic ndicators. Surgery 2003; 134:827-34.
42. Peng G, Guo Z, Kiniwa Y., Voo KS, Peng W, Fu T, et al Toll-like receptor 8-mediated reversal of CD4 +regulatory Tcell function. Science 2005; 309:1380-4.
43. Ye J, Huang X, Hsueh E.C., Zhang Q., Ma C, Zhang Y, et al Human regulatory T cells induce T-lymphocyte senescence. Blood 2012; 120: 2021-31.
44. Yang J, Richmond A. The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan. Mol Ther 2004; 9:846-55.
45. Rabinovich GA, Gabrilovich D, Sotomayor EM Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 2007; 25:267-96.
46. Tan W, Zhang W, Strasner A., Grivennikov S, Cheng JQ, Hoffman R.M., et al Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasisthrough RANKL-RANK signalling. Nature 2011; 470:548-53.
47. Kono K, Kawaida H, Takahashi A., Sugai H, Mimura K, Miyagawa N., et al CD4(+)CD25 high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol Immunother 2006; 55:1064-71.
48. + regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 2003; 98:1089-99.
49. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198:1875-86.
50. +T regulatory cells: role of tumor-derived TGF-beta. J Immunol 2007; 178:2883-92.
51. Datta D, Flaxenburg JA, Laxmanan S, Geehan C., Grimm M, Waaga-Gasser AM, et al Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer. Cancer Res 2006; 66: 9509-18.
52. Qian C, An H, Yu Y., Liu S, Cao X. TLR agonists induce regulatory dendritic cells to recruit Th1 cells via preferential IP-10 secretion and nhibit Th1 proliferation. Blood 2007; 109:3308-15.